Sleep Apnea Monitoring - SAM™

Proactive management of comorbidities. Early detection, long-term risk reduction. 1–6

Healthcare Professionals Cardiac Rhythm Management Sleep Apnea Monitoring

Sleep apnea + cardiovascular comorbidities

= a dangerous combination

Severe sleep apnea is strongly associated with and has a negative impact on cardiovascular comorbidities:

  • 58% higher risk of heart failure2
  • Risk of atrial fibrillation is 4-times higher3
  • More Resistance to pharmacological treatment4
  • More recurrence of atrial fibrillation after ablation or cardioversion5,6
Capture décran 2020 10 20 à 15 14 49

Sleep apnea is highly prevalent, yet underdiagnosed.7–9

  • Severe Sleep Apnea burden (RDI >20) was identified in 31.1 % of patients of an unselected pacemaker population9
  • 50-90% of patients are undiagnosed and therefore, untreated8
Sleep Apnea Monitoring SAM proposal bis 2

Protect patients with SAM

SAM is a unique Sleep Apnea Monitoring tool which has been validated against the gold standard Apnea Hypopnea Index determined by polysomnography.1

A reliable screening tool, SAM has a high specificity of 85% and a high sensitivity of 89%.

Quick and efficient follow-up

SAM detects and reports severe sleep apnea allowing for quick and efficient follow-up to manage this dangerous disorder.1

Click here to download the study
Sleep Apnea Monitoring SAM dream study 3

Availability of select products and their functions varies by country. Please check with your representative for further information.

Related products:

ALIZEA; BOREA; KORA 250; KORA 100; REPLY 200; REPLY CRT-P

REFERENCES

  1. Defaye P, et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: The DREAM European study. Heart Rhythm. 2014;11:842–8.
  2. Gottlieb DJ, Yenokyan G, Newman AB et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122:352–60.
  3. Mehra R, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–6.
  4. Monahan K, et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012;110:369–72.
  5. Kanagala R, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.
  6. Ng CY, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:47–51.
  7. Bradley TD and Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009; 373: 82-93.
  8. Lee W, et al. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med. 2008;2:349–64.
  9. Marti-Almor J et al. Incidence of sleep apnea and association with atrial fibrillation in an unselected pacemaker population: Results of the observational RESPIRE study. Heart Rhythm 2020;17(2):195-202 pii: S1547-5271(19)30822-7. doi: 10.1016/j.hrthm.2019.09.001.